---
title: "Regis Healthcare Ltd. (REG) Gets a Hold from Jarden"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298172870.md"
description: "Jarden analyst Steven Wheen maintained a Hold rating on Regis Healthcare Ltd. (REG) with a price target of A$6.20, as shares closed at A$4.30. Additionally, Ord Minnett's Tom Godfrey issued a Hold rating on September 3, contrasting with a previous Buy rating from the same firm in August."
datetime: "2026-09-07T06:05:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298172870.md)
  - [en](https://longbridge.com/en/news/298172870.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298172870.md)
generator: "portal-rs"
---

# Regis Healthcare Ltd. (REG) Gets a Hold from Jarden

In a report released on September 3, Steven Wheen from Jarden maintained a Hold rating on Regis Healthcare Ltd., with a price target of A$6.20. The company’s shares closed today at A$4.30.

Wheen covers the Healthcare sector, focusing on stocks such as Ramsay Health Care, Regis Healthcare Ltd., and Telix Pharmaceuticals. According to TipRanks, Wheen has an average return of 9.1% and a 50.37% success rate on recommended stocks. 

In addition to Jarden, Regis Healthcare Ltd. also received a Hold from Ord Minnett’s Tom Godfrey in a report issued on September 3. However, on August 25, Ord Minnett maintained a Buy rating on Regis Healthcare Ltd. (ASX: REG).

### Related Stocks

- [REG.AU](https://longbridge.com/en/quote/REG.AU.md)
- [RHC.AU](https://longbridge.com/en/quote/RHC.AU.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)
- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)

## Related News & Research

- [RBC Capital downgrades Regis Healthcare Ltd. (REG) to a Hold](https://longbridge.com/en/news/297977637.md)
- [UBS Sticks to Its Hold Rating for Regis Healthcare Ltd. (REG)](https://longbridge.com/en/news/297840632.md)
- [Ord Minnett downgrades Regis Healthcare Ltd. (REG) to a Hold](https://longbridge.com/en/news/297843353.md)
- [Macquarie Keeps Their Hold Rating on Region Group (SCPAF)](https://longbridge.com/en/news/298185411.md)
- [Shaw and Partners Keeps Their Buy Rating on Polymetals Resources Ltd. (POL)](https://longbridge.com/en/news/298422932.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**